NEW YORK (GenomeWeb News) – Thirteen European research institutes and universities will work together using €6 million ($7.8 million) in funding from the European Commission to develop biomarker-based technologies for determining the health status of kidney transplants.

Led by France's National Institute of Health and Medical Research, or INSERM, the Biomarkers of Renal Graft Injuries in Kidney Allograft Recipients consortium includes several partnering institutes in France, Belgium, and Germany, and one in Sweden, INSERM said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.